Facility Will Enhance Enzo’s Ability to Produce and Distribute Its Growing Portfolio of Molecular Assays, Immunohistochemistry, Immunoassays and Immuno-oncology Products and Services Anticipates Significant Tax and Other Incentives for Enzo’s Entire Farmingdale New York Campus NEW YORK, NY – Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostic and therapeutics company, announced today that, as part of […]

Enabling Growing Genomic Applications in Chinese Clinical Market SAN DIEGO–Illumina, Inc. (NASDAQ:ILMN) today announced that its MiSeq™Dx Sequencing Systemreceived the approval certificate from the China National Drug Administration (CNDA). This is Illumina’s first CNDA-cleared, next-generation sequencing (NGS) system in China. In accordance with the clearance, Illumina can now market and sell the MiSeqDx Sequencing System to hospitals […]

Thermo Scientific FAIMS Pro device delivers selectivity and productivity in high-resolution mass spectrometry FLORENCE, Italy — IMSC 2018 – Proteomic scientists can now take advantage of a next-generation differential ion mobility device that seamlessly integrates with high-resolution mass spectrometers to provide workflow efficiency and data quality for experiments ranging from the discovery of disease biomarkers to the identification of […]

PORTLAND, OR – August 22, 2018 – MolecularMD today announces it has validated Thermo Fisher Scientific’s Oncomine™ Tumor Mutation Load Assay for clinical research trials to aid immunotherapy drug development programs for the pharmaceutical industry. The latest approach in the evolving field of immuno-oncology, tumor mutation burden (TMB) analysis is rapidly becoming an independent predictor […]

Two innovative companies with unique technologies unite, creating powerful tools for researches and companies developing the treatments of tomorrow. During recent years, 3D-Bioprinting has emerged as a powerful cell culture technology but has also been hampered by the lack of a biologically relevant Bioink. Today, CELLINK launches a brand new Bioink containing BIOLAMININS, that will […]

Eppendorf is a renowned innovator in the field of PCR Instruments and consumables with roughly 30 years of experience in developing and producing PCR equipment. Now Eppendorf extends its range of PCR accessories with a new software application to control up to fifty Mastercycler X50 eco modules remotely. The CycleManager X50 support the PCR workflow […]

NESS ZIONA, Israel All-by-all full genome comparison of 30+ varieties to rapidly improve nutrition and hardiness and reduce resource requirements NRGene, the leading genomic big data company, has constructed a comprehensive soy genome diversity-haplotype database based on results from GenoMAGICTM, allowing commercial and academic researchers never-before-available insights into the genomic diversity within the soybean crop. The database contains de novo assemblies and all-to-all […]

On August 22, BGI, the world’s leading genomics organization, signed a Memorandum of Understanding (MoU) with Xing Technologies Pty Ltd ((hereafter referred to as XING), a spin-off company from University of Queensland, focusing on translating diagnostic technologies. The two sides are intended to apply their advantages on collaborative research and innovation of cutting-edge life sciences […]

San Carlos, CA NuGEN Technologies, a leading provider of NGS library preparation solutions, today announced the launch of new mRNA-Seq library preparation kits integrated with NuQuant library quantification method. This proprietary library quantification method enables direct measurement of NGS library molar concentration, or the number of sequenceable molecules in seconds. The NuQuant method eliminates the need to serially dilute […]

AMSBIO produce a growing range of experimental cell lines, recombinant proteins and screening services to advance the search for new Chimeric Antigen Receptor (CAR T) cell therapies to treat cancers. For years, the foundations of cancer treatment were surgery, chemotherapy, and radiation therapy. Over the last twenty years, therapeutic drugs that target cancer cells by homing in […]